TW280810B - - Google Patents
Info
- Publication number
- TW280810B TW280810B TW083107264A TW83107264A TW280810B TW 280810 B TW280810 B TW 280810B TW 083107264 A TW083107264 A TW 083107264A TW 83107264 A TW83107264 A TW 83107264A TW 280810 B TW280810 B TW 280810B
- Authority
- TW
- Taiwan
- Prior art keywords
- remedy
- linear
- branched alkyl
- hydrogen atom
- represents hydrogen
- Prior art date
Links
- 230000000694 effects Effects 0.000 abstract 3
- 102000029816 Collagenase Human genes 0.000 abstract 2
- 108060005980 Collagenase Proteins 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 229960002424 collagenase Drugs 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 101000645291 Bos taurus Metalloproteinase inhibitor 2 Proteins 0.000 abstract 1
- 229940122097 Collagenase inhibitor Drugs 0.000 abstract 1
- 101000669513 Homo sapiens Metalloproteinase inhibitor 1 Proteins 0.000 abstract 1
- 102100039364 Metalloproteinase inhibitor 1 Human genes 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 239000002442 collagenase inhibitor Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- AQYSYJUIMQTRMV-UHFFFAOYSA-N hypofluorous acid Chemical group FO AQYSYJUIMQTRMV-UHFFFAOYSA-N 0.000 abstract 1
- 125000006533 methyl amino methyl group Chemical group [H]N(C([H])([H])[H])C([H])([H])* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 125000001064 morpholinomethyl group Chemical group [H]C([H])(*)N1C([H])([H])C([H])([H])OC([H])([H])C1([H])[H] 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP21812493 | 1993-08-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW280810B true TW280810B (en, 2012) | 1996-07-11 |
Family
ID=16715014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW083107264A TW280810B (en, 2012) | 1993-08-09 | 1994-08-09 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5795891A (en, 2012) |
| EP (1) | EP0712838B1 (en, 2012) |
| KR (1) | KR100312097B1 (en, 2012) |
| CN (1) | CN1038583C (en, 2012) |
| AT (1) | ATE172959T1 (en, 2012) |
| DE (1) | DE69414396T2 (en, 2012) |
| DK (1) | DK0712838T3 (en, 2012) |
| ES (1) | ES2123808T3 (en, 2012) |
| TW (1) | TW280810B (en, 2012) |
| WO (1) | WO1995004715A1 (en, 2012) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9501737D0 (en) * | 1994-04-25 | 1995-03-22 | Hoffmann La Roche | Hydroxamic acid derivatives |
| JP2000500761A (ja) | 1995-11-23 | 2000-01-25 | ブリティッシュ バイオテック ファーマシューティカルズ リミテッド | 金属タンパク質分解酵素阻害剤 |
| US6462023B1 (en) | 1996-09-10 | 2002-10-08 | British Biotech Pharmaceuticals, Ltd. | Cytostatic agents |
| CN1060804C (zh) * | 1997-03-17 | 2001-01-17 | 中国科学院微生物研究所 | Iv型胶原酶特异性人源基因工程抗体 |
| WO2001052891A1 (fr) * | 2000-01-20 | 2001-07-26 | Nippon Organon K. K. | Inhibiteurs d'invasion plasmodiale dans des erythrocytes |
| BR112021006407A8 (pt) | 2018-10-04 | 2022-12-06 | Inst Nat Sante Rech Med | uso de inibidores do egfr para ceratodermas |
| CN110554118A (zh) * | 2019-10-15 | 2019-12-10 | 宁夏师范学院 | 一种检测尿液中萘酚含量的方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4743587A (en) * | 1985-09-10 | 1988-05-10 | G. D. Searle & Co. | Hydroxamic acid based collagenase inhibitors |
| FR2609289B1 (fr) * | 1987-01-06 | 1991-03-29 | Bellon Labor Sa Roger | Nouveaux composes a activite d'inhibiteurs de collagenase, procede pour les preparer et compositions pharmaceutiques contenant ces composes |
| WO1992022523A2 (en) * | 1991-06-14 | 1992-12-23 | Research Corporation Technologies, Inc. | Peptide derivatives of collagenase inhibitor |
-
1994
- 1994-08-03 US US08/596,278 patent/US5795891A/en not_active Expired - Fee Related
- 1994-08-03 CN CN94193055A patent/CN1038583C/zh not_active Expired - Fee Related
- 1994-08-03 AT AT94923067T patent/ATE172959T1/de not_active IP Right Cessation
- 1994-08-03 ES ES94923067T patent/ES2123808T3/es not_active Expired - Lifetime
- 1994-08-03 KR KR1019960700667A patent/KR100312097B1/ko not_active Expired - Fee Related
- 1994-08-03 DK DK94923067T patent/DK0712838T3/da active
- 1994-08-03 WO PCT/JP1994/001284 patent/WO1995004715A1/ja active IP Right Grant
- 1994-08-03 DE DE69414396T patent/DE69414396T2/de not_active Expired - Fee Related
- 1994-08-03 EP EP94923067A patent/EP0712838B1/en not_active Expired - Lifetime
- 1994-08-09 TW TW083107264A patent/TW280810B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| EP0712838B1 (en) | 1998-11-04 |
| DE69414396D1 (de) | 1998-12-10 |
| ES2123808T3 (es) | 1999-01-16 |
| DE69414396T2 (de) | 1999-07-15 |
| WO1995004715A1 (fr) | 1995-02-16 |
| KR960703843A (ko) | 1996-08-31 |
| CN1133034A (zh) | 1996-10-09 |
| DK0712838T3 (da) | 1999-07-19 |
| CN1038583C (zh) | 1998-06-03 |
| US5795891A (en) | 1998-08-18 |
| KR100312097B1 (ko) | 2002-11-13 |
| EP0712838A4 (en) | 1996-03-19 |
| EP0712838A1 (en) | 1996-05-22 |
| ATE172959T1 (de) | 1998-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LU91943I2 (fr) | Tafluprost et ses dérivés pharmaceutiquement acceptables (SAFLUTAN®) | |
| ATE109149T1 (de) | 3-pyrrolidinylthio-1-azabicyclo(3.2.0>-hept-2-e - 2-carbonsäureverbindungen. | |
| HU9500240D0 (en) | New prolin-amide derivatives and pharmaceutical compositions containing them as active component | |
| DE68925223D1 (de) | 3-Alkenyl-1-azabicyclo(3.2.0)hept-2-en-2-carbonsäure-Verbindungen | |
| NO20014119D0 (no) | Medikament inneholdende et sulfopyranosylacylglycerolderivat | |
| TW280810B (en, 2012) | ||
| NO985202D0 (no) | Anti-heliobacter pylori-preparater inneholdende 1-metylcarbapenemderivater | |
| EP0546177A4 (en) | BENZOPYRANE DERIVATIVE, PRODUCTION THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME. | |
| DE3476160D1 (en) | Derivatives of benzoic acid for use as a medicament and use of these derivatives as conserving or disinfecting agent | |
| MX9206930A (es) | Nuevos compuestos | |
| DK0420224T3 (da) | Anthihepatopatisk middel | |
| GR3031767T3 (en) | Cyclopropane derivatives and antiviral agents containing the same. | |
| ATE112682T1 (de) | Isocarbacyclinderivate enthaltende antidiabetika. | |
| ES2061579T3 (es) | Compuestos cefem y procedimientos para su preparacion. | |
| EP0272849A3 (en) | Use of 2-oxo-imidazolidine derivatives in the treatment of kidney diseases |